05
Dec
2008
FerroKin Biosciences (San Carlos, CA) early-stage developer of iron chelator for treatment of anemias, closed a $15M Series A financing. Participants include Clarus Ventures, Burrill & Co. and Celegene Inc.
OnBioVC PARTNERS
-
05
Dec
2008
FerroKin Biosciences (San Carlos, CA) early-stage developer of iron chelator for treatment of anemias, closed a $15M Series A financing. Participants include Clarus Ventures, Burrill & Co. and Celegene Inc.